NRGene Technologies Ltd (TLV:NRGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 112.00
0.00 (0.00%)
Sep 10, 2026, 11:28 AM IDT
NRGene Technologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.93 | 3.17 | 1.29 | 2 | 3.16 | 4.46 | |
Revenue Growth | 140.56% | 145.74% | -35.53% | -36.66% | -29.22% | -36.56% |
Cost of Revenue | 1.05 | 1.25 | 1.02 | 1.1 | 1.45 | 2 |
Gross Profit | 1.88 | 1.92 | 0.27 | 0.9 | 1.71 | 2.47 |
Selling, General & Admin | 2.32 | 2.15 | 2.91 | 4 | 4.78 | 7.49 |
Research & Development | 1.34 | 1.34 | 1.81 | 2.18 | 2.43 | 3.53 |
Other Operating Expenses | -0 | - | -1.2 | -0.59 | -0.14 | -0.16 |
Operating Expenses | 3.65 | 3.49 | 3.52 | 5.59 | 7.07 | 10.87 |
Operating Income | -1.78 | -1.57 | -3.25 | -4.69 | -5.36 | -8.4 |
Interest Expense | -0.07 | -0.03 | -0.05 | -0.07 | -0.29 | -0.41 |
Interest & Investment Income | - | 0.01 | 0.12 | 0.26 | 0.14 | 0.22 |
Currency Exchange Gain (Loss) | 0.08 | 0.08 | -0.15 | -0.13 | -0.52 | 0.22 |
Other Non Operating Income (Expenses) | - | - | -0.01 | 0.02 | -0.19 | 0.07 |
EBT Excluding Unusual Items | -1.77 | -1.52 | -3.33 | -4.62 | -6.21 | -8.3 |
Gain (Loss) on Sale of Assets | -0.01 | -0.01 | 0 | 0 | - | - |
Asset Writedown | - | - | -0.06 | -0.61 | - | - |
Pretax Income | -1.78 | -1.53 | -3.39 | -5.23 | -6.21 | -8.3 |
Income Tax Expense | 0.04 | 0.04 | -0.01 | 0.01 | -0.01 | 0.04 |
Earnings From Continuing Operations | -1.81 | -1.56 | -3.38 | -5.24 | -6.21 | -8.34 |
Minority Interest in Earnings | 0.19 | 0.06 | 0.02 | - | - | - |
Net Income | -1.63 | -1.5 | -3.36 | -5.24 | -6.21 | -8.34 |
Net Income to Common | -1.63 | -1.5 | -3.36 | -5.24 | -6.21 | -8.34 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 13 | 13 | 13 | 13 | 12 | 12 |
Shares Outstanding (Diluted) | 13 | 13 | 13 | 13 | 12 | 12 |
Shares Change | 4.18% | 3.16% | 1.13% | 0.69% | 3.20% | 37.44% |
EPS (Basic) | -0.12 | -0.11 | -0.26 | -0.42 | -0.50 | -0.69 |
EPS (Diluted) | -0.12 | -0.11 | -0.26 | -0.42 | -0.50 | -0.69 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.55 | 0.74 | -3.69 | -4.06 | -6.34 | -6.07 |
Free Cash Flow Per Share | 0.04 | 0.06 | -0.29 | -0.32 | -0.51 | -0.50 |
Gross Margin | 64.03% | 60.57% | 20.70% | 45.03% | 54.16% | 55.23% |
Operating Margin | -60.68% | -49.53% | -252.17% | -234.53% | -169.52% | -188.26% |
Profit Margin | -55.53% | -47.38% | -260.39% | -262.02% | -196.49% | -186.82% |
Free Cash Flow Margin | 18.60% | 23.19% | -286.12% | -202.80% | -200.54% | -136.05% |
EBITDA | -1.69 | -1.48 | -3 | -4.5 | -5.19 | -8.37 |
EBITDA Margin | -57.51% | -46.56% | -232.71% | -224.94% | -164.42% | -187.47% |
D&A For EBITDA | 0.09 | 0.09 | 0.25 | 0.19 | 0.16 | 0.04 |
EBIT | -1.78 | -1.57 | -3.25 | -4.69 | -5.36 | -8.4 |
EBIT Margin | -60.68% | -49.53% | -252.17% | -234.53% | -169.52% | -188.26% |